世界中医药
文章摘要
引用本文:李媛1,刘殿娜2,代岳雯1,孙静宜2,胡凯文2.ⅢB-Ⅳ期非小细胞肺癌多中心回顾性队列研究[J].世界中医药,2023,(10):.  
ⅢB-Ⅳ期非小细胞肺癌多中心回顾性队列研究
ⅢB-Ⅳ Stage Non-small Cell Lung Cancer:A Multicenter Retrospective Cohort Study
投稿时间:2021-10-13  
DOI:10.3969/j.issn.1673-7202.2023.10.012
中文关键词:  冷消融  中药  化疗  治疗模式  生存分析  生命质量  评估
English Keywords:Cryoablation  Chinese medicine  Chemotherapy  Treatment mode  Survival analysis  Quality of life  Assessment
基金项目:国家重点研发计划项目(2018YFC1705102);首都卫生发展科研专项项目(2018-1-4201)
作者单位
李媛1,刘殿娜2,代岳雯1,孙静宜2,胡凯文2 1 北京中医药大学北京100029 2 北京中医药大学东方医院北京100078 
摘要点击次数: 471
全文下载次数: 0
中文摘要:
      目的:探讨冷消融联合中药及化疗对ⅢB-Ⅳ期非小细胞肺癌患者生存期及生命质量的影响。方法:采用多中心回顾性队列研究的方法,纳入ⅢB-Ⅳ期非小细胞肺癌患者,经中药联合冷消融治疗患者133例,经化疗患者40例。比较2组患者生存期,绘制Kaplan-Meier生存曲线,分析实验室检查及生命质量评分差异,比较2种治疗模式对患者的影响。结果:冷消融联合中药与化疗治疗ⅢB-Ⅳ期非小细胞肺癌2组患者生存期比较差异无统计学意义。结论:冷消融联合中药与化疗比较可以显著提高患者治疗后生命质量,改善不良反应,在一定意义上冷消融联合中药治疗模式可以替代化疗。
English Summary:
      To explore the effect of cryoablation combined with Chinese medicine and chemotherapy on the survival and quality of life of patients with stage ⅢB-Ⅳ non-small cell lung cancer.Methods:A multicenter retrospective cohort study was carried out.Patients with stage ⅢB-Ⅳ non-small cell lung cancer treated with cryoablation combined with Chinese medicine(n=133) or chemotherapy(n=40) were enrolled.The survival period of the patients in the two groups was compared and Kaplan-Meier survival curves were plotted.Differences in laboratory tests and quality of life scores were analyzed to compare the effect of the two treatment modes on patients.Results:There was no statistically significant difference in the survival period between the cryoablation combined with the Chinese medicine group and the chemotherapy group.Conclusion:Cryoablation combined with Chinese medicine significantly improved the quality of life of patients and reduced adverse reactions as compared with chemotherapy.In this sense,cryoablation combined with Chinese medicine treatment may be a replacement for chemotherapy.
查看全文  查看/发表评论  下载PDF阅读器